Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 27 citing Kim: Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent.... (0.07 sec) 

Evidence-based and potential benefits of metformin in the polycystic ovary …


S Palomba, A Falbo, F Zullo, F Orio Jr - Endocrine Reviews, 2009 - Endocrine Soc
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2 diabetes
mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin resistant,
metformin was introduced in clinical practice to treat these patients also. Moreover, ...
Cited by 13 - Related articles - All 6 versions

Relationship between AMPK and the transcriptional balance of clock-related genes …

- physiology.org
E Vieira, EC Nilsson, A Nerstedt, M … - American Journal of …, 2008 - Am Physiological Soc
Circadian clocks coordinate physiological, behavioral, and biochemical events with predictable
daily environmental changes by a self-sustained transcriptional feedback loop. CLOCK and ARNTL
are transcriptional activators that regulate Per and Cry gene expression. PER and CRY ...
Cited by 4 - Related articles - All 3 versions

Effects of 7 days of exercise training on insulin sensitivity and responsiveness in …

- 192.35.79.232 [PDF] 
JP Kirwan, TPJ Solomon, DM Wojta, MA … - American Journal of …, 2009 - Am Physiological Soc
The objectives of this study were to determine whether 1) the improvement in insulin action induced
by short-term exercise training in patients with type 2 diabetes is due to an improvement in insulin
sensitivity, an improvement in insulin responsiveness, or a combination of improved ...
Cited by 3 - Related articles - All 7 versions

[PDF] Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear …


YS Lee, DK Kim, YD Kim, KC Park, M Shong, HA … - Biochemical …, 2008 - biochemjusa.org
SHP (small heterodimer partner; NR0B2) is an atypical orphan NR (nuclear receptor) that functions
as a transcriptional co- repressor by interacting with a diverse set of NRs and transcrip- tional
factors. HNF-6 (hepatocyte nuclear factor-6) is a key regu- latory factor in pancreatic ...
Cited by 1 - Related articles - View as HTML - All 7 versions

Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP- …

- physiology.org
D Chanda, SJ Kim, IK Lee, M Shong, … - American Journal of …, 2008 - Am Physiological Soc
Sodium arsenite has been demonstrated to alter the expression of genes associated with glucose
homeostasis in tissues involved in the pathogenesis of type 2 diabetes; however, the underlying
molecular mechanism has not been fully elucidated yet. In this study, we report that the ...
Cited by 1 - Related articles - All 4 versions

The impact of CYP2E1 on the development of alcoholic liver disease as studied in …


A Butura, K Nilsson, K Morgan, TR Morgan, SW French, … - Journal of Hepatology, 2009 - Elsevier
CYP2E1 metabolizes ethanol, generates reactive oxygen species, and is suggested to be important
for development of alcoholic liver disease. The present study aims to evaluate the role of CYP2E1
in combination with ethanol for development of alcoholic liver disease using mice ...
Cited by 1 - Related articles - All 23 versions

Molecular mechanisms involved in NAFLD progression


M Malaguarnera, M Di Rosa, F Nicoletti, L … - Journal of Molecular …, 2009 - Springer
Abstract Non-alcoholic fatty liver disease (NAFLD) is an emerging metabolic-related disorder
characterized by fatty infiltration of the liver in the absence of alcohol consump- tion. NAFLD
ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), which might ...
Cited by 2 - Related articles - All 2 versions

Fenofibrate differentially regulates PAI-1 gene expression via AMPK-dependent …


D Chanda, CH Lee, YH Kim, JR Noh, DK Kim, JH … - Hepatology, 2009 - interscience.wiley.com
Plasminogen activator inhibitor type I (PAI-1) is a marker of the fibrinolytic system, and serves
as a possible predictor for hepatic metabolic syndromes. Fenofibrate, a peroxisome
proliferator-activated receptor (PPAR ) agonist, is a drug used for treatments of ...
Related articles

AMPK Activators–Potential Therapeutics for Metabolic and Other Diseases


G Zhou, IK Sebhat, BB Zhang - Acta Physiologica, 2009 - interscience.wiley.com
AMP-activated protein kinase (AMPK) mediated cellular metabolic responses to tissue specific
and whole body stimuli play a vital role in the control of energy homeostasis. As a cellular energy
sensing mechanism, AMPK activation stimulates glucose uptake and fat oxidation while it ...
Related articles - All 3 versions

AMPK in the regulation of hepatic energy metabolism: from physiology to …


B Viollet, B Guigas, J Leclerc, S Hébrard, … - Acta physiologica ( …, 2009 - interscience.wiley.com
Because the liver is central in the maintenance of glucose homeostasis and energy storage,
knowledge of the physiology as well as physiopathology of hepatic energy metabolism is a prerequisite
to our understanding of whole body metabolism. Hepatic fuel metabolism changes ...
Related articles - All 3 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google